Get started
Author

Mark Van Buskirk

Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation
2011 · Bruno Sangro, Livio Carpanese, et al. · Hepatology · 655
PDF
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer
2016 · Guy A. van Hazel, Volker Heinemann, et al. · Journal of Clinical Oncology · 354
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma
2004 · Jean Francois H. Geschwind, Riad Salem, et al. · Gastroenterology · 354
Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model
1988 · K.Peter Rentrop, John C. Thornton, et al. · The American Journal of Cardiology · 228
Treatment of Unresectable Hepatocellular Carcinoma with Intrahepatic Yttrium 90 Microspheres: Factors Associated with Liver Toxicities
2005 · James E. Goin, Riad Salem, et al. · Journal of Vascular and Interventional Radiology · 170
Left-Liver Hypertrophy After Therapeutic Right-Liver Radioembolization Is Substantial but Less Than After Portal Vein Embolization
2013 · Benjamin Garlipp, Thierry de Baere, et al. · Hepatology · 166
PDF
90Y Microsphere (TheraSphere) Treatment for Unresectable Colorectal Cancer Metastases of the Liver: Response to Treatment at Targeted Doses of 135–150 Gy as Measured by [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomographic Imaging
2005 · Robert J. Lewandowski, Kenneth G. Thurston, et al. · Journal of Vascular and Interventional Radiology · 162
Treatment of Unresectable Hepatocellular Carcinoma with Intrahepatic Yttrium 90 Microspheres: A Risk-Stratification Analysis
2005 · James E. Goin, Riad Salem, et al. · Journal of Vascular and Interventional Radiology · 111
Hepatic Toxicity After Radioembolization of the Liver Using 90Y-Microspheres: Sequential Lobar Versus Whole Liver Approach
2011 · Ricarda Seidensticker, Max Seidensticker, et al. · CardioVascular and Interventional Radiology · 85
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies
2018 · Peter Gibbs, Volker Heinemann, et al. · Clinical Colorectal Cancer · 67
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study
2014 · SIRFLOX Study Group, Peter Gibbs, et al. · BMC Cancer · 63
PDF
The impact of combining Selective Internal Radiation Therapy (SIRT) with Sorafenib on overall survival in patients with advanced hepatocellular carcinoma: The Soramic trial palliative cohort
2018 · J. Ricke, B. Sangro, et al. · Journal of Hepatology · 40
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 + selective internal radiation therapy (SIRT) ± bev in patients (pts) with metastatic colorectal cancer (mCRC).
2015 · Peter Gibbs, Volker Heinemann, et al. · Journal of Clinical Oncology · 35
Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization
2016 · Kazim H. Narsinh, Mark Van Buskirk, et al. · Radiology · 29
Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies
2018 · on behalf of the European Network on Radioembolization with Yttrium-90 resin microspheres (ENRY), Bruno Sangro, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 26
Improvements in anthropometric measures and gastrointestinal tolerance in patients with cystic fibrosis by using a digestive enzyme cartridge with overnight enteral nutrition
2022 · Sara J. Hendrix, Patrick A. Flume, et al. · Nutrition in Clinical Practice · 11
PDF
Photobiomodulation Treatment with a Home-Use Device for COVID-19: A Randomized Controlled Trial for Efficacy and Safety
2024 · Lew Lim, Nazanin Hosseinkhah, et al. · Photobiomodulation Photomedicine and Laser Surgery · 5
Home-use Photobiomodulation Device Treatment Outcomes for COVID-19
2022 · Lew Lim, Nazanin Hosseinkhah, et al. · medRxiv · 2
PDF
Photobiomodulation for cognitive dysfunction (Brain Fog) in post-COVID-19 condition: a randomized double-blind sham-controlled pilot trial
2026 · Lew Lim, Nazanin Hosseinkhah, et al. · EClinicalMedicine · 1
Using data from the SIRFLOX study to evaluate depth of response within a volumetric model in patients with metastatic colorectal cancer
2017 · N Sharma, G van Hazel, et al. · Journal of Vascular and Interventional Radiology · 1
SIRFLOX: Differences in site of first progression between mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 ± bev + selective internal radiation therapy (SIRT) in first-line patients (pts) with metastatic colorectal cancer (mCRC).
2016 · Peter Gibbs, Volker Heinemann, et al. · Journal of Clinical Oncology · 1
O-019 SIRFLOX: Randomized trial comparing first-line mFOLFOX6 ± bevacizumab versus mFOLFOX6 + selective internal radiation therapy (SIRT) ± bevacizumab in patients with metastatic colorectal cancer (mCRC) – analysis by presence or absence of extra-hepatic metastases and bevacizumab treatment
2015 · G.A. van Hazel, V. Heinemann, et al. · Annals of Oncology · 1
PDF
O-014 Evaluation of depth of response within a volumetric model in patients with metastatic colorectal cancer: results of the SIRFLOX study
2016 · V. Heinemann, G. van Hazel, et al. · Annals of Oncology
PDF
P-063 Effect of age on treatment effect and tolerability of SIRT when added to mFOLFOX chemotherapy in patients with metastatic colorectal cancer (mCRC) – results from the SIRFLOX study
2016 · G. van Hazel, V. Heinemann, et al. · Annals of Oncology
SIRFLOX study: Novel approach to define depth of response (DpR) within a volumetric model in patients with metastatic colorectal cancer (mCRC).
2016 · Volker Heinemann, Guy A. Van Hazel, et al. · Journal of Clinical Oncology
Works count: 28
Citation count: 2,567
H-index: 15
I10-index: 16
Year
Topic
Type